Do Comorbidities Influence Objective and Subjective Recovery Rates of Nasal Polyposis?

dc.authoridBayindir, Tuba/0000-0003-4150-5016
dc.authoridMiman, Murat Cem/0000-0002-2139-9239
dc.authoridyucel ekici, nur/0000-0001-5074-4575
dc.authorwosidBayindir, Tuba/ABG-9517-2020
dc.authorwosidMiman, Murat Cem/AAZ-4873-2020
dc.contributor.authorAkarcay, Mustafa
dc.contributor.authorEkici, Nur
dc.contributor.authorMiman, Murat C.
dc.contributor.authorFirat, Yezdan
dc.contributor.authorBayindir, Tuba
dc.contributor.authorSelimoglu, Erol
dc.date.accessioned2024-08-04T20:32:18Z
dc.date.available2024-08-04T20:32:18Z
dc.date.issued2010
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectives: To investigate the clinical and laboratory outcomes both objectively and subjectively in nasal polyposis patients with or without comorbidity (CoM; asthma and allergy). Patients and Methods: Thirty-three nasal polyposis patients (13 women and 20 men) were included into the study. Their mean age was 39.23 +/- 9.13 years. CoM(+) and CoM(-) nasal polyposis patients were compared with each other. Evaluations contained endoscopic nasal examination, acoustic rhinometry, rhinomanometry, visual analog scale score of nasal blockage, olfactory function score, respiratory function test, skin prick tests, and paranasal sinus computed tomography. Results: Recovery was statistically significant in all observed evaluations for endoscopic and radiologic staging, nasal obstruction, and sense of smell compared with the first evaluation in all patients regardless of the subgroups. Although objective measurements of respiratory functions did not show any change, clinical improvement was detected in CoM(+) patients with a decrease of need to their antiasthmatic medical treatment. Conclusions: Results of CoM(+) patients led to no statistical difference when compared with CoM(-) subgroup. When applying predefined nasal polyposis treatment protocol, the polyp patients with CoMs do not need close follow-up compared to the patients without CoMs.en_US
dc.identifier.doi10.1097/SCS.0b013e3181c3b785
dc.identifier.endpage74en_US
dc.identifier.issn1049-2275
dc.identifier.issn1536-3732
dc.identifier.issue1en_US
dc.identifier.pmid20072025en_US
dc.identifier.scopus2-s2.0-77649202192en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage71en_US
dc.identifier.urihttps://doi.org/10.1097/SCS.0b013e3181c3b785
dc.identifier.urihttps://hdl.handle.net/11616/94991
dc.identifier.volume21en_US
dc.identifier.wosWOS:000273902400015en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal of Craniofacial Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNasal polyposisen_US
dc.subjectallergyen_US
dc.subjectasthmaen_US
dc.subjectcomorbidity VASen_US
dc.subjectrhinometryen_US
dc.subjectoutcomeen_US
dc.titleDo Comorbidities Influence Objective and Subjective Recovery Rates of Nasal Polyposis?en_US
dc.typeArticleen_US

Dosyalar